In reply: You oughta be congratulated?
Author: Martin B Van Der Weyden
Published online: 7 October 2002
In reply: "Oh what a feeling" to receive a congratulatory letter! But the euphoria was short lived, as, on closer inspection, congratulations turned to castigation. The offending event was the Journal's publication of an industry-supported supplement,1 and its practice of branding supplements with the logos of their sponsoring bodies.
Although sponsorship by government agencies or non-profit health organisations rarely provokes comment, industry sponsorship is another matter. As industry support for research and other health-related activities will inevitably increase in the future, we at the Journal are pleased that Padiglione and colleagues have aired their anxiety.
Irrespective of the source of sponsorship, the Journal's policy governing the publication of supplements follows the recommendations of the International Committee of Medical Journal Editors.2 These include that:
the journal's editor must take full responsibility for policies, practices and content of supplements, must approve the appointment of the editors of supplements, and must retain the authority to reject articles; and
the source of funding should be clearly stated and prominently located in supplements, preferably on each page.
To these principles the Journal has added its own requirements.3 These include the need for peer review and that editors of and contributors to supplements declare competing interests and compensations. These were clearly identified on the title page of the offending publication.1
For our readers, the Journal is the bread and its supplements the butter. One can always refuse to taste the butter. But, for those who hanker after a little fat, we aim to ensure, through churning by external peer review and transparent sponsorship of the product, that "butter is better".
References
- Gibson RA, editor. Essential role of fats throughout the lifecycle. Med J Aust 2002; 176 (Suppl 3 June): S105-S124. <eMJA full text>
- International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals and separate statements <http://www.mja.com.au/public/information/uniform.html> (accessed 9 September 2002).
- MJA policy on sponsored supplements <http://www.mja.com.au/public/information/instruc.html#Supplements>
Using generative artificial intelligence in clinical practice: a narrative review and proposed agenda for implementation
Ian A Scott, Sandeep Reddy, Tanya Kelly, Tim Miller, Anton Vegt
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, John D Blakey, Shyamali C Dharmage, Paul Foster, Peter G Gibson, Adam Jaffe, Alan James, Christine R Jenkins, Sundram Sivamalai, Peter D Sly, Guy B Marks, Vanessa M McDonald, Judy Wetttenhall
CURE Asthma: a unique opportunity for Australia
Anthony Flynn, Wendy Edmondson, Alan James, Caroline Lodge, Vanessa M McDonald, Christine R Jenkins, John Blakey, Gary P Anderson
Evidence from Australian cohort studies about asthma trajectories and transitions across the life course: a narrative review
Caroline Lodge, Xin Dai, Ingrid A. Laing, Michael P Menden, Anthony Flynn, Gary P Anderson, Sarath Ranganathan, Shyamali C Dharmage
Technological advances in the search for a CURE for asthma
Sara Quon, Timothy M Johanson, Ridhima Wadhwa, Alen Faiz, Anthony Flynn, Gary P Anderson, Amanda J Cox, Nicholas P West, Michael P Menden, Rhys S Allan
Protecting public interest journalism as a public health good
Bronwyn Fredericks, Neha Lalchandani, Melissa A Sweet, Alex Cramb, Carmel Williams